SNT 10.6% 5.2¢ syntara limited

PXS vs fibrosis

  1. 11 Posts.
    lightbulb Created with Sketch. 5
    “Phaqrmaxis is an Australian pharmaceutical research company focussed on inflammation and fibrosis with a portfolio of products at various stages ...”

    Am not a medical guy, but isn’t that the exact havoc the damn COVID19 causing to patients?

    Curious has any PXS product ever been developed/tested for fibrosis of lungs? Come on PXS guys, you can do better. Crack the nuts, not just for the PS, more importantly for the human being.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.